Published in European Radiology Experimental, 2019
SUMANTRA DEY
1ST YR PDT
BACKGROUND
• Prostate MRI is becoming of central importance in the
contemporary management of PCa by improving the
detection of clinically significant cancer (csPCa) while
minimising overdiagnosis and overtreatment of indolent
disease
• CURRENT USES OF MRI
– detecting and localising csPCa lesions
– triaging biopsy, guiding targeted biopsy or focal therapy
– stratifying the risk before treatment
– monitoring patients during active surveillance
– Planning and choosing surgery or radiation therapy techniques
– assessing recurrence
THE MULTIPARAMETRIC STANDARD
• ESUR guidelines 2012
– defined mpMRI as the combination of anatomic T2-
weighted imaging (T2WI) with at least two functional MRI
techniques out of DWI, DCE and MRS
– proposed detailed and stringent technical requirements
for detection and staging
– DWI and DCE to be used mandatorily and MRSI optionally
• protocols were presented together with the first
version of the prostate imaging reporting and data
system (PI-RADS)
THE MULTIPARAMETRIC STANDARD
• PI-RADS version 2 (2014) led to consistent
simplification of several technical and
interpretation aspects
– MRSI was excluded from the examination,
restricting the mp standard to the use of T2WI,
DWI, and DCE
– less (even if stringent) technical parameters to
obtain an acceptable mpMRI examination, leaving
space for protocols optimisation
– introducing the concept of dominant sequence
Dominant Sequence
• Likelihod that an image represents csPCa is
expressed on a 1 to 5 scale
• Depends on appearance on DWI for the peripheral
zone (PZ) and on T2WI for the transition zone (TZ)
• DCE assigned secondary role of a tiebreaker for PZ
lesions, DWI for TZ lesions
Brief discussion on mpMRI
T2WI
DWI
• DWI study consists of 2 images
1. High b value DWI image
2. Apparent Diffusion Coefficient map
• normal PZ demonstrates homogenous low SI
on DWI and high SI on ADC map
• More restricted environment of cancer leads
to high SI on DWI and low SI on the ADC map
DCE
(A) Axial T2WI
of the prostate
midgland shows a
1.2-cm circumscribed
hypointense nodule
(arrow) in the
enlarged right
transition
zone.
(B)The nodule is
hyperintense on high
b-value DWI
(C)hypointense on
ADC map
(D)shows early
enhancement on the
axial contrast
enhanced
T1WI DCE
(A) Axial T2WI
shows a lenticular,
noncircumscribed
mass with low
signal intensity in
the anterior
midgland (arrows)
compatible with a
PI-RADS category
5 lesion.
(B) mass shows
markedly high
signal intensity on
high b-value DWI
(C)markedly low
signal intensity on
ADC map
(D) early
enhancement on
contrast-
enhanced T1WI
DCE
THE MP STANDARD - DISADVANTAGES
• mpMRI requires prolonged time (30–45 min)
• use of IV gadolinium-based contrast agents
• drawbacks of PIRADS v2
– Incomplete interpretation criteria for TZ cancers
– lack of definite rules for the CZ or anterior
fibromuscular stroma involvement
• High costs
Less-is-better strategies
1. Non-contrast biparametric MRI
2. Reduced acquisition time
3. Abbreviated protocols
4. Less variability from human readers
Non-contrast biparametric MRI
• Anatomic T2WI coupled with DWI as the only retained functional
technique
• DCE has been classically assumed to improve the sensitivity of
T2WI alone or T2WI combined with DWI
• Whether DCE should be included in the mp standard has always
been a controversial issue
• PI-RADS v2 revised role for DCE to PZ only and limiting it to a
problem-solving tool
• bpMRI does not apply to the setting of tumour recurrence after
radical prostatectomy, radiation therapy, or focal therapy - DCE still
plays a key-role in this scenario
Reduced acquisition time
• T2WI is obtained with 2D turbo spin-echo sequences -
need to acquire transverse, sagittal, and coronal planes
separately; most time consuming
• (3D) volumetric T2WI provides a unique slab with
isotropic voxels, to be reconstructed in any plane –
shortened acquisition time up to 44%
• reduce volume-averaging artefacts, leading to better
delineation of subtle anatomic features affecting the
diagnosis (“erased charcoal sign” around TZ nodules)
Reduced acquisition time
• Trade offs with 3D slab technique –
– reduced soft tissue contrast
– blurring and loss of resolution even for subtle
motion
– greater motion artefacts
• 3D T2WI is not yet accepted as a state-of-the-
art tool for detecting and staging PCa
Abbreviated protocols
• consist of cutting redundant scans while
preserving the informative core of the test
• Abbreviated bpMRI - transverse T2WI and
DWI only, with total acquisition time of 8 min
45 s (compared to 34 min 19 s of mpMRI)
• Technical solution to face the increasing
demand for prostate imaging
• needs further validation and should be
investigated in terms of cost-effectiveness
Less variability from human readers
• Computer-aided diagnosis (CAD) algorithms –
a form of machine learning technology,
trained on real cases to extract and classify
image features, and in turn recognise
intermediate- to-high-risk cancers
Different-is-better strategies
• there is a parallel pathway of prostate MRI
development, searching for objective and
reproducible MRI-related biomarkers for the
prediction of PCa aggressiveness or
overcoming inter-reader variability
Promised DIFFERENT STRATEGIES
TAKE HOME MESSAGE
• Multiparametric magnetic resonance imaging is the standard of
care for assessing prostate cancer.
• Alternative protocols are emerging to increase availability and offer
a patient-centred approach.
• Less-is-better strategies are promising for clinical practice, but
require validation.
• Different-is-better strategies are a matter for intensive research.
• Prostate MRI technical standard and interpretation rules are still
evolving.
THANK YOU

MP MRI PROSTATE.pptx

  • 1.
    Published in EuropeanRadiology Experimental, 2019 SUMANTRA DEY 1ST YR PDT
  • 2.
    BACKGROUND • Prostate MRIis becoming of central importance in the contemporary management of PCa by improving the detection of clinically significant cancer (csPCa) while minimising overdiagnosis and overtreatment of indolent disease • CURRENT USES OF MRI – detecting and localising csPCa lesions – triaging biopsy, guiding targeted biopsy or focal therapy – stratifying the risk before treatment – monitoring patients during active surveillance – Planning and choosing surgery or radiation therapy techniques – assessing recurrence
  • 3.
    THE MULTIPARAMETRIC STANDARD •ESUR guidelines 2012 – defined mpMRI as the combination of anatomic T2- weighted imaging (T2WI) with at least two functional MRI techniques out of DWI, DCE and MRS – proposed detailed and stringent technical requirements for detection and staging – DWI and DCE to be used mandatorily and MRSI optionally • protocols were presented together with the first version of the prostate imaging reporting and data system (PI-RADS)
  • 4.
    THE MULTIPARAMETRIC STANDARD •PI-RADS version 2 (2014) led to consistent simplification of several technical and interpretation aspects – MRSI was excluded from the examination, restricting the mp standard to the use of T2WI, DWI, and DCE – less (even if stringent) technical parameters to obtain an acceptable mpMRI examination, leaving space for protocols optimisation – introducing the concept of dominant sequence
  • 5.
    Dominant Sequence • Likelihodthat an image represents csPCa is expressed on a 1 to 5 scale • Depends on appearance on DWI for the peripheral zone (PZ) and on T2WI for the transition zone (TZ) • DCE assigned secondary role of a tiebreaker for PZ lesions, DWI for TZ lesions
  • 6.
  • 7.
  • 9.
  • 10.
    • DWI studyconsists of 2 images 1. High b value DWI image 2. Apparent Diffusion Coefficient map • normal PZ demonstrates homogenous low SI on DWI and high SI on ADC map • More restricted environment of cancer leads to high SI on DWI and low SI on the ADC map
  • 12.
  • 14.
    (A) Axial T2WI ofthe prostate midgland shows a 1.2-cm circumscribed hypointense nodule (arrow) in the enlarged right transition zone. (B)The nodule is hyperintense on high b-value DWI (C)hypointense on ADC map (D)shows early enhancement on the axial contrast enhanced T1WI DCE
  • 15.
    (A) Axial T2WI showsa lenticular, noncircumscribed mass with low signal intensity in the anterior midgland (arrows) compatible with a PI-RADS category 5 lesion. (B) mass shows markedly high signal intensity on high b-value DWI (C)markedly low signal intensity on ADC map (D) early enhancement on contrast- enhanced T1WI DCE
  • 16.
    THE MP STANDARD- DISADVANTAGES • mpMRI requires prolonged time (30–45 min) • use of IV gadolinium-based contrast agents • drawbacks of PIRADS v2 – Incomplete interpretation criteria for TZ cancers – lack of definite rules for the CZ or anterior fibromuscular stroma involvement • High costs
  • 17.
    Less-is-better strategies 1. Non-contrastbiparametric MRI 2. Reduced acquisition time 3. Abbreviated protocols 4. Less variability from human readers
  • 18.
    Non-contrast biparametric MRI •Anatomic T2WI coupled with DWI as the only retained functional technique • DCE has been classically assumed to improve the sensitivity of T2WI alone or T2WI combined with DWI • Whether DCE should be included in the mp standard has always been a controversial issue • PI-RADS v2 revised role for DCE to PZ only and limiting it to a problem-solving tool • bpMRI does not apply to the setting of tumour recurrence after radical prostatectomy, radiation therapy, or focal therapy - DCE still plays a key-role in this scenario
  • 20.
    Reduced acquisition time •T2WI is obtained with 2D turbo spin-echo sequences - need to acquire transverse, sagittal, and coronal planes separately; most time consuming • (3D) volumetric T2WI provides a unique slab with isotropic voxels, to be reconstructed in any plane – shortened acquisition time up to 44% • reduce volume-averaging artefacts, leading to better delineation of subtle anatomic features affecting the diagnosis (“erased charcoal sign” around TZ nodules)
  • 21.
    Reduced acquisition time •Trade offs with 3D slab technique – – reduced soft tissue contrast – blurring and loss of resolution even for subtle motion – greater motion artefacts • 3D T2WI is not yet accepted as a state-of-the- art tool for detecting and staging PCa
  • 22.
    Abbreviated protocols • consistof cutting redundant scans while preserving the informative core of the test • Abbreviated bpMRI - transverse T2WI and DWI only, with total acquisition time of 8 min 45 s (compared to 34 min 19 s of mpMRI) • Technical solution to face the increasing demand for prostate imaging • needs further validation and should be investigated in terms of cost-effectiveness
  • 23.
    Less variability fromhuman readers • Computer-aided diagnosis (CAD) algorithms – a form of machine learning technology, trained on real cases to extract and classify image features, and in turn recognise intermediate- to-high-risk cancers
  • 24.
    Different-is-better strategies • thereis a parallel pathway of prostate MRI development, searching for objective and reproducible MRI-related biomarkers for the prediction of PCa aggressiveness or overcoming inter-reader variability
  • 25.
  • 26.
    TAKE HOME MESSAGE •Multiparametric magnetic resonance imaging is the standard of care for assessing prostate cancer. • Alternative protocols are emerging to increase availability and offer a patient-centred approach. • Less-is-better strategies are promising for clinical practice, but require validation. • Different-is-better strategies are a matter for intensive research. • Prostate MRI technical standard and interpretation rules are still evolving.
  • 27.